ACUVUE® OASYS With Transitions™ Light Intelligent Technology™ Clinical Performance Registry
NCT ID: NCT04116736
Last Updated: 2025-05-23
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
146 participants
OBSERVATIONAL
2019-10-19
2023-03-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of ACUVUE® OASYS 1-Day for Astigmatism Contact Lenses With Alternative Lidstock
NCT05713552
Clinical Performance of Two Daily Disposable Silicone Hydrogel Contact Lenses
NCT05554640
Evaluation of ACUVUE OASYS® 1-Day for Astigmatism Lenses Produced on a New Manufacturing Line
NCT04794270
Clinical Evaluation of Spherical Soft Contact Lenses, Toric Soft Contact Lenses and Spectacles in Low Astigmats
NCT05056870
Changes in Inflammatory Biomarkers When Symptomatic Contact Lens Wearers Are Refit in Acuvue Oasys 1-Day Lenses
NCT05120128
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TEST Lens
Eligible subjects that are at least 18 years old, who have been recently fitted (within the last 2 months) with the ACUVUE® OASYS with Transitions™ will be asked to complete follow-up assessments performed online at approximately 2-weeks, 4-months, and 12-months following Visit 1.
ACUVUE® OASYS with Transitions™
JJVC Marketed Contact Lens
CONTROL Lens
Eligible subjects that are at least 18 years old, who have been recently fitted (within the last 2 months) with spherical non-photochromic reusable marketed silicone hydrogel contact lenses (of any brand) will be asked to complete follow-up assessments performed online at approximately 2-weeks, 4-months, and 12-months following Visit 1.
Silicone Hydrogel Contact Lens
Any reusable spherical silicone hydrogel brand that is approved and marketed in the country conducting the study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACUVUE® OASYS with Transitions™
JJVC Marketed Contact Lens
Silicone Hydrogel Contact Lens
Any reusable spherical silicone hydrogel brand that is approved and marketed in the country conducting the study.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Contact lens neophytes or those who have recently (i.e. within last 2 months) begun the use of a new lens type and have purchased a supply of lenses.
* A minimum age of 18 years, with no maximum age.
* The registrant must read and sign the Informed Consent form.
* The registrant must appear able and willing to adhere to the instructions set forth in this clinical protocol.
Exclusion Criteria
* Current participant in another research study.
* Employee or relative of site, or family member of Recruiting Practitioner or Johnson \& Johnson.
* Non-spherical contact lens wearers, i.e. toric or multifocal lenses.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Vision Care, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johnson & Johnson Vision Care, Inc Clinical Trial
Role: STUDY_DIRECTOR
Johnson & Johnson Vision Care, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sanchez Rubal Ltd. - Sanchez Bregua
A Coruña, , Spain
Sanchez Rubal Ltd - Finisterre
A Coruña, , Spain
Optica Ronda
Almería, , Spain
Natural Optics Balaguer
Balaguer, , Spain
Centro Optico Raga
Linares, , Spain
Centro Optico Montero
Madrid, , Spain
Centro Boston de Optometria
Madrid, , Spain
Cirugia Ocular de Madrid
Madrid, , Spain
Opticalia Real Villa
Madrid, , Spain
Opticas ClaraVision
Ontinyent, , Spain
Centro Optico
Seville, , Spain
Eyesite Opticians
Reading, Berkshire, United Kingdom
Leightons Insight Marlow
Marlow, Buckinghamshire, United Kingdom
P Shah Opticians
London, England, United Kingdom
Eyes On the Common Ltd.
London, England, United Kingdom
Hodd Barnes Dickens Ltd
London, England, United Kingdom
Eyesite Opticians
Winchester, Hampshire, United Kingdom
First Contact Opticians Ltd.
Eastcote, Middlesex, United Kingdom
Urquhart Opticians Ltd
Kilmarnock, Scotland, United Kingdom
Eyesite Opticians
Weybridge, Surrey, United Kingdom
Auckland Opticians
Horbury, Wakefield, United Kingdom
Chalmers Opticians Ltd
Cardiff, Wales, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-6334
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.